Literature DB >> 9793106

Addiction to benzodiazepines.

C Salzman1.   

Abstract

Benzodiazepines are sedative hypnotic medications that can induce a state of dependence. Dependence however is not the same as addiction. The development of dependence is a predictable phenomenon, influenced by dose, duration of treatment, and a number of other factors including individual characteristics of the benzodiazepine user. It is unclear whether there are meaningful differences among benzodiazepines in producing a state of dependence. Benzodiazepine dependence is also characterized by a predictable discontinuation syndrome. Benzodiazepines are rarely abused by non-substance abusers. The regulation of benzodiazepines although the legitimate therapeutic use has been significantly reduced.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9793106     DOI: 10.1023/a:1022125929946

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  20 in total

Review 1.  Appropriate use and regulatory control of benzodiazepines.

Authors:  R I Shader; D J Greenblatt; M B Balter
Journal:  J Clin Pharmacol       Date:  1991-09       Impact factor: 3.126

Review 2.  Relative abuse liability of different benzodiazepines in drug abusers.

Authors:  R R Griffiths; B Wolf
Journal:  J Clin Psychopharmacol       Date:  1990-08       Impact factor: 3.153

Review 3.  The benzodiazepine controversy: therapeutic effects versus dependence, withdrawal, and toxicity.

Authors:  C Salzman
Journal:  Harv Rev Psychiatry       Date:  1997 Jan-Feb       Impact factor: 3.732

4.  Has the New York State triplicate benzodiazepine prescription regulation influenced sedative-hypnotic overdoses?

Authors:  R S Hoffman; M G Wipfler; M A Maddaloni; R S Weisman
Journal:  N Y State J Med       Date:  1991-10

5.  Commentary on review by Woods and Winger. Benzodiazepines: long-term use among patients is a concern and abuse among polydrug abusers is not trivial.

Authors:  R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 6.  Issues and controversies regarding benzodiazepine use.

Authors:  C Salzman
Journal:  NIDA Res Monogr       Date:  1993

Review 7.  Use of benzodiazepines in anxiety disorders.

Authors:  R I Shader; D J Greenblatt
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

Review 8.  Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.

Authors:  R R Griffiths; E M Weerts
Journal:  Psychopharmacology (Berl)       Date:  1997-11       Impact factor: 4.530

9.  New epidemiologic findings about insomnia and its treatment.

Authors:  M B Balter; E H Uhlenhuth
Journal:  J Clin Psychiatry       Date:  1992-12       Impact factor: 4.384

10.  Benzodiazepine use among injecting heroin users.

Authors:  S G Darke; J E Ross; W D Hall
Journal:  Med J Aust       Date:  1995-06-19       Impact factor: 7.738

View more
  6 in total

Review 1.  Hooked on benzodiazepines: GABAA receptor subtypes and addiction.

Authors:  Kelly R Tan; Uwe Rudolph; Christian Lüscher
Journal:  Trends Neurosci       Date:  2011-02-25       Impact factor: 13.837

2.  Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward.

Authors:  Lauren M Reynolds; Elif Engin; Gabriella Tantillo; Hew Mun Lau; John W Muschamp; William A Carlezon; Uwe Rudolph
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

3.  Self-Reported Sedative Drug Use Among Students Attending at University of Gondar, Gondar, Northwest, Ethiopia: A Cross-Sectional Study.

Authors:  Gashaw Binega Mekonnen; Simachew Gidey Debeb; Nurahmed Seid Getaw; Zemene Demelash Kifle
Journal:  Subst Abuse Rehabil       Date:  2021-08-16

4.  Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.

Authors:  Elif Engin; Konstantin I Bakhurin; Kiersten S Smith; Rochelle M Hines; Lauren M Reynolds; Wannan Tang; Rolf Sprengel; Stephen J Moss; Uwe Rudolph
Journal:  Neuropsychopharmacology       Date:  2014-02-19       Impact factor: 7.853

5.  Does accreditation improve pro re nata benzodiazepines administration in psychiatric inpatients? Pre-post accreditation medical record comparison.

Authors:  Mohammed Abdullah Al-Sughayir
Journal:  Int J Ment Health Syst       Date:  2017-02-02

6.  Educating and informing patients receiving psychopharmacological medications: are family physicians in Pakistan up to the task?

Authors:  Hammad Ashraf Ganatra; Hadi Bhurgri; Roomasa Channa; Fauzia Ahmad Bawany; Syed Nabeel Zafar; Rafia Ishfaq Chaudhry; Syeda Hina Batool; Abdul Basit; Mehmood Asghar; Sarah Saleem; Haider Naqvi
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.